PEAK6 Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$187K Buy
+5,731
New +$173K ﹤0.01% 3385
2015
Q4
Sell
-40,961
Closed -$734K 4769
2015
Q3
$672K Buy
+40,961
New +$700K ﹤0.01% 2604
2014
Q4
Sell
-39,018
Closed -$499K 4668
2014
Q3
$461K Buy
39,018
+35,968
+1,179% +$453K ﹤0.01% 2548
2014
Q2
$39K Buy
+3,050
New +$39.7K ﹤0.01% 4138
2014
Q1
Sell
-295,140
Closed -$3.55M 4881
2013
Q4
$3.55M Sell
295,140
-81,660
-22% -$965K 0.02% 981
2013
Q3
$2.21M Buy
376,800
+240,500
+176% +$2.6M 0.02% 1447
2013
Q2
$1.26K Buy
+136,300
New +$1.16M ﹤0.01% 1934

Other funds holding BSX

PEAK6 Group's BSX Position: Q2 2018 in Review

PEAK6 Group opened a new position in Boston Scientific (BSX) in Q2 2018: 5,731 shares worth $187K. The stake represents ﹤0.01% of the portfolio and ranks #3385 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in BSX as recently as Q3 2015.

PEAK6 Group first reported a position in BSX in Q2 2013 and has held it in 7 quarters since. The position peaked at $3.55M in Q4 2013. 671 funds tracked by Wall St. Rank hold BSX as of Q2 2018.

  • PEAK6 Group held 5,731 shares of Boston Scientific worth $187K as of Q2 2018.
  • Boston Scientific was a new PEAK6 Group position in Q2 2018.
  • Boston Scientific made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #3385 holding.
  • PEAK6 Group first reported a position in Boston Scientific in Q2 2013 and has held it in 7 quarters since.
  • PEAK6 Group's Boston Scientific position peaked at $3.55M in Q4 2013.
  • 671 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.